• Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings

    Read more
  • Redx to present RXC008 Phase 1 Data at ECCO

    Read more
  • Redx to Present Preclinical Data on RXC008 in an Oral Presentation at ECM Congress

    Read more